SS Innovations Is A Compelling Surgical Robotics Growth Play

Eborose Capital1.17K FollowersFollow5ShareSavePlay(7min)CommentsSummarySS Innovations achieved record Q4 revenue of $14.5m, capping a fiscal year with 106% top-line growth driven by increased sales volume.Sequential revenue growth in Q4 was partially offset by a decline in gross margin, highlighting some profitability challenges amid rapid expansion.SSII’s investment thesis includes a significant upside on potential US approval of the SSi Mantra, which could materially impact future growth and valuation. Ignatiev/iStock via Getty Images Earlier this month, SS Innovations (SSII) reported strong top-line growth in the fourth quarter of FY25, pushing the business to a record quarter in revenue terms. SSII reported revenue of $14.5m, up 13.2% from Q3. This rounded off aThis article was written byEborose Capital1.17K FollowersFollowI work in Restructuring Advisory in London and write about businesses that interest me here on Seeking Alpha. The companies that I work with are generally facing some form of distress. I then work with these busineses to implement restructuring solutions including solvent actions like debt refinancing's to insolvent solutions including administrations under the UK Insolvency Act.My work within the restructuring space primarily focuses on smaller businesses, therefore most of my coverage on here will be on mid-cap equities or those experiencing distress.If you want to reach out, whether that's to ask me any questions or just to connect, feel free to message me here on Seeking Alpha.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.